Chemotherapy Devices Market

Market Snapshot

Chemotherapy Devices Market: By Product, Application and Region

Market Synopsis:

Global Chemotherapy Devices market is valued at USD 11.54 Billion in 2021 and is projected to attain a value of USD 23.12 Billion by 2028 at a CAGR of 7.5% during the forecast period, 2022–2028. Chemotherapy is given intravenously with the help of a venous access device (VAD). Cannulas, catheters, and implanted ports are only a few of the devices accessible. The gadget selected is determined by the sort of therapy a patient will receive as well as the patient's physical condition. A central venous access device (CVAD) is a non-irritating device constructed of silicone that can be left in place for weeks or months. CVADs can be used to give fluids and medications as well as take blood samples. The external and internal jugular veins, as well as the subclavian veins, are the most common locations for central venous access devices. The cephalic vein in the deltopectoral groove, the axillary vein, and the femoral vein are all possible entry points.

The rising prevalence of cancer and the failure of traditional cancer treatments to adequately treat the disease has fueled demand for innovative immunotherapy-based therapeutics such Chemotherapy Devices. According to the National Cancer Institute, 16.8 million new instances of cancer were diagnosed in the United States in 2016, with an estimated 595,690 deaths from the disease. By 2024, the number of cancer patients is predicted to reach 19 million. In addition, the World Health Organization (WHO) recorded around 14 million cancer cases and 8.2 million cancer-related deaths in 2012. Lung, colorectal, prostate, cervical, and breast cancer were among the most common occurrences, which has resulted in a substantial increase in demand for peptide vaccines, which has aided in the growth of the Chemotherapy Devices industry.

Rising Cancer Incidences

According to research published by the World Health Organization (WHO), cancer is the second biggest cause of death worldwide, accounting for 9.6 million deaths in 2018. The key causes of the rise in cancer incidence rates are rising tobacco and alcohol consumption, as well as a growing senior population. Tobacco smoking is a substantial risk factor for cancer, according to the Global Burden of Disease 2015 research, accounting for roughly 22% of cancer deaths globally.

Furthermore, as the incidence of cancer rises, so does the demand for treatment, propelling the worldwide chemotherapy devices market forward. According to the National Cancer Institute (NCI), 15.5 million cancer survivors were recorded in the United States in 2016, with the number likely to rise.

Discomfort to Patients

Patients may experience discomfort as a result of chemotherapy equipment. The needle or guide wire can damage the top of the lung during the insertion of a skin-tunneled catheter or port, generating an air pocket. There may be bruising at the location where the needle entered the vein, or an artery or nerve may be damaged. Furthermore, infection is a possibility. The risk is usually one to three in every 100 instances, although it might be higher based on a variety of other circumstances, such as diagnosis or therapy. There's also the possibility of a clot forming around the port. The CVAD can split, become damaged, or become dislocated if it is not in the proper position, so it must be replaced.

The Chemotherapy Devices market scope can be tabulated as below:

Market Segmentation:

The Global Chemotherapy Devices Market can be segmented by Product into Catheter, Cannula, Pump and Others. Based on Application into Hospital, Clinics and Home Care. Based on Region, the Chemotherapy Devices Market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

North America to Continue Dominating the Chemotherapy Devices Market

In 2021, North America held the greatest proportion of the global market for Chemotherapy Devices, followed by Europe. The increase in the number of cancer patients, improved health care infrastructure, increased government investments, and other, and ongoing projects will boost the market in the North American region. Furthermore, the rising prevalence of cancer is likely to boost Chemotherapy Devices market growth.

Key Players:

Key participants operating in the Chemotherapy Devices market are: Advanced Chemotherapy Technologies (US), Baxter International (US), Becton Dickinson (US), B. Braun (Germany), Fresenius Kabi (Germany), Halyard Health (US), ICU Medical (US), Moog Inc (US), Micrel Medical (Sweden), Smiths Group (UK), Terumo Corporation (Japan), and Zyno Medical (US).

The Chemotherapy Devices market is segmented as follows: